Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction. uri icon

authors

  • Selvaraj, Senthil
  • Newgard, Christopher B
  • Borlaug, Barry A
  • Dalane W Kitzman, MD
  • Shah, Sanjiv J
  • Margulies, Kenneth B
  • Husain, Mansoor
  • Inzucchi, Silvio E
  • McGuire, Darren K
  • Lanfear, David E
  • Javaheri, Ali
  • Patel, Shachi
  • Umpierrez, Guillermo
  • Mentz, Robert J
  • Sharma, Kavita
  • Kosiborod, Mikhail N
  • Shah, Svati H
  • Sauer, Andrew J
  • McGarrah, Robert W
  • Jones, Philip
  • Kwee, Lydia Coulter
  • Windsor, Sheryl L
  • Ilkayeva, Olga
  • Muehlbauer, Michael J

publication date

  • October 18, 2024